An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases¶
Liu, P. (2020). An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases. Frontiers in Immunology.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Domain-specific¶
- Isoelectric Point
- A protein's modified charge variant can have a different measured pI, and an experimental focusing position estimates the property under the assay's conditions.
This sourceMain-peak pI and the later charge-variant-based selection are separate reported facts.
- A protein's modified charge variant can have a different measured pI, and an experimental focusing position estimates the property under the assay's conditions.
Verification¶
Does it exist? Not checked yet. This work's DOI is recorded above but has not been resolved against an external catalogue, so nothing here confirms the work exists.
Does it back the claim? Not recorded. The single citation of this work carries no recorded support check.
Support is checked per citation rather than per work — the same source can be cited soundly in one article and wrongly in another. Per-citation recording began recently, so a citation with no recorded check is a gap in the record rather than evidence it went unchecked.
See how references were verified.
Registry ID ref:86d6b2b3c52d · see in the full table